World's Best Scientists 2026 revealed!
Martha Q. Lacy

Martha Q. Lacy

Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
120
Citations
57527
World Ranking
557
National Ranking
332

Medicine

D-Index
125
Citations
59683
World Ranking
3089
National Ranking
1706

Martha Q. Lacy publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Martha Q. Lacy sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,137 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Martha Q. Lacy D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Martha Q. Lacy sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 125 D-Index — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Martha Q. Lacy is affiliated with the Mayo Clinic in the United States. Their body of research primarily revolves around hematology, molecular biology, and oncology, with a notable emphasis on multiple myeloma and related hematologic disorders.

The scientist has contributed extensively to the study of multiple myeloma, amyloidosis, protein degradation, and chronic lymphocytic leukemia. Their key research topics include:

  • Multiple Myeloma Research and Treatments
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Protein Degradation and Inhibitors
  • Chronic Lymphocytic Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Cancer Treatment and Pharmacology
  • Peptidase Inhibition and Analysis

Their recent publications illustrate a consistent focus on genetic and clinical aspects of hematologic malignancies, particularly multiple myeloma. Selected works include:

  • "Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response," 2020, Blood Cancer Journal
  • "Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities," 2020, Blood Advances
  • "Mortality trends in multiple myeloma after the introduction of novel therapies in the United States," 2021, Leukemia
  • "A simple additive staging system for newly diagnosed multiple myeloma," 2022, Blood Cancer Journal
  • "Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update," 2021, Mayo Clinic Proceedings

The scientist frequently collaborates with peers who have also made substantial contributions in related fields. Their frequent co-authors include:

  • Morie A. Gertz
  • Angela Dispenzieri
  • Shaji Kumar
  • Prashant Kapoor
  • Francis K. Buadi

Publications by this scientist have appeared in journals known for hematology and oncology research, such as:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Blood Cancer Journal
  • American Journal of Hematology
  • Journal of Clinical Oncology

Martha Q. Lacy's academic contributions chiefly fall within:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Their specialized subfields include:

  • Hematology
  • Molecular Biology
  • Oncology
  • Genetics
  • Public Health, Environmental and Occupational Health

Best Publications

  • Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

    Robert A. Kyle;Morie A. Gertz;Thomas E. Witzig;John A. Lust

  • Improved survival in multiple myeloma and the impact of novel therapies

    Shaji K. Kumar;S. Vincent Rajkumar;Angela Dispenzieri;Martha Q. Lacy

  • Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

    S K Kumar;A Dispenzieri;M Q Lacy;M A Gertz

  • Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

    Shaji Kumar;Angela Dispenzieri;Martha Q. Lacy;Suzanne R. Hayman

  • Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial

    Jesús Fernando San Miguel;Jesús Fernando San Miguel;Katja Weisel;Philippe Moreau;Martha Lacy

  • Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis

    Angela Dispenzieri;Morie A. Gertz;Robert A. Kyle;Martha Q. Lacy

  • POEMS syndrome: definitions and long-term outcome.

    Angela Dispenzieri;Robert A. Kyle;Martha Q. Lacy;S. Vincent Rajkumar

  • A Trial of Three Regimens for Primary Amyloidosis: Colchicine Alone, Melphalan and Prednisone, and Melphalan, Prednisone, and Colchicine

    Robert A. Kyle;Morie A. Gertz;Philip R. Greipp;Thomas E. Witzig

  • Combination Therapy With Thalidomide Plus Dexamethasone for Newly Diagnosed Myeloma

    S. Vincent Rajkumar;Suzanne Hayman;Morie A. Gertz;Angela Dispenzieri

  • Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial.

    Paul Gerard Richardson;Pieter Sonneveld;Michael Schuster;David Irwin

  • Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines

    Shaji K. Kumar;Joseph R. Mikhael;Francis K. Buadi;David Dingli

  • Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy

    Morie A. Gertz;Martha Q. Lacy;Angela Dispenzieri;Philip R. Greipp

  • Clinical course of patients with relapsed multiple myeloma.

    Shaji K. Kumar;Terry M. Therneau;Morie A. Gertz;Martha Q. Lacy

  • Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study.

    Paul G. Richardson;David S. Siegel;Ravi Vij;Craig C. Hofmeister

  • Genetic aberrations and survival in plasma cell leukemia.

    R E Tiedemann;N Gonzalez-Paz;R A Kyle;R Santana-Davila

  • Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple Myeloma

    Martha Q. Lacy;Suzanne R. Hayman;Morie A. Gertz;Angela Dispenzieri

  • Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation.

    Angela Dispenzieri;Morie A. Gertz;Robert A. Kyle;Martha Q. Lacy

  • Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma.

    Luis F. Porrata;Morie A. Gertz;David J. Inwards;Mark R. Litzow

  • Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma.

    S Kumar;A Dispenzieri;M Q Lacy;S R Hayman

  • Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma. Commentary

    Michele Cavo;S. Vincent Rajkumar;Suzanne R. Hayman;Martha Q. Lacy

Frequent Co-Authors

Morie A. Gertz
Morie A. Gertz Mayo Clinic
Shaji Kumar
Shaji Kumar Mayo Clinic
Francis K. Buadi
Francis K. Buadi Mayo Clinic
David Dingli
David Dingli Mayo Clinic
Robert A. Kyle
Robert A. Kyle Mayo Clinic
Nelson Leung
Nelson Leung Mayo Clinic
John A. Lust
John A. Lust Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine doesn’t always mean medical school is the only path. If you’re interested in the healthcare field but looking for flexibility or alternative routes, there are several affordable online programs that can launch your career.

Pursuing a bachelor of health information management online can help you build a strong foundation in managing medical data and health records, which is a critical area in today’s digital healthcare environment.

Interested in administrative roles? Earning your medical coding certification online can prepare you for in-demand jobs handling billing processes and ensuring compliance with healthcare regulations.

Nursing remains one of the most respected and needed professions. If you’re considering this path, you might wonder what is the cheapest online college for nursing? Researching affordable programs can help you achieve your goals without overwhelming student debt.

Finally, those aiming to advance their nursing careers may look into the cheapest online fnp programs to become a Family Nurse Practitioner. These online degrees offer flexibility while providing specialized knowledge to serve communities better.

Best Scientists Citing Martha Q. Lacy

Trending Scientists

Recently Published Articles